Miaoyu Chen
State Key Laboratory Of Virology
Wuhan, 430062, China
Wuhan, 430062, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Multivalent mRNA vaccine platform with compatible antigens conferred broad-spectrum protection against orthoebolaviruses' exposure.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 18, 2026
The oral nucleoside drug VV116 is a promising candidate for treating Nipah virus infection.
Journal: Emerging microbes & infections
Published: November 19, 2025
Complete protection against lethal Nipah virus challenge by intranasal vaccination with bacteriophage T4 coupled with Nipah virus G or F protein.
Journal: Vaccine
Published: November 18, 2025
Divergent Pathogenesis of 2 Chinese Crimean-Congo Hemorrhagic Fever Viruses in Cynomolgus Macaques.
Journal: The Journal of infectious diseases
Published: October 18, 2025
mRNA-lipid nanoparticle vaccines provide protection against lethal Nipah virus infection.
Journal: NPJ vaccines
Published: August 13, 2025
A highly potent nanobody-based bispecific therapeutic provides broad-spectrum protection against ebolavirus.
Journal: Nature communications
Published: August 04, 2025
Single-dose intranasal AdC68-vectored vaccines rapidly protect Syrian hamsters against lethal Nipah virus infection.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: October 13, 2024
A highly effective ferritin-based divalent nanoparticle vaccine shields Syrian hamsters against lethal Nipah virus.
Journal: Frontiers in immunology
Published: February 18, 2024
An attachment glycoprotein nanoparticle elicits broadly neutralizing antibodies and protects against lethal Nipah virus infection.
Journal: NPJ vaccines
Published: February 14, 2024
Showing 1-12 of 12
Last Updated: 09/26/2026